Severe peripheral arterial disease during nilotinib therapy

Tools

Item Type:	Letter
Title:	Severe peripheral arterial disease during nilotinib therapy
Creators Name:	Le Coutre, P., Rea, D., Abruzzese, E., Dombret, H., Trawinska, M.M., Herndlhofer, S., Doerken, B. and Valent, P.
Keywords:	Amputation, Angioplasty, Antineoplastic Agents, BCR-ABL Positive Chronic Myelogenous Leukemia, Drug Tolerance, Drug Administration Schedule, Peripheral Arterial Disease, Piperazines, Protein-Tyrosine Kinases, Pyrimidines, Retrospective Studies, Risk Factors, Severity of Illness Index, Stents
Source:	Journal of the National Cancer Institute
ISSN:	0027-8874
Publisher:	Oxford University Press
Volume:	103
Number:	17
Page Range:	1347-1348
Date:	7 September 2011
Official Publication:	https://doi.org/10.1093/jnci/djr292
PubMed:	View item in PubMed

Repository Staff Only: item control page